Literature DB >> 16133040

Calciphylaxis in pediatric end-stage renal disease.

Abubakr A Imam1, Tej K Mattoo, Gaurav Kapur, David A Bloom, Rudolph P Valentini.   

Abstract

Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients. The exact etiology is unknown, but the disease is commonly associated with a high calcium-phosphorus product and elevated levels of parathyroid hormone (PTH). We herein review the published reports on calciphylaxis in ESRD patients less than 18 years old and report the case of a patient with severe calciphylaxis who presented with lower extremity pain, muscle tenderness and difficulty in walking. The serum PTH was low, and the calcium-phosphorus product was normal. The diagnosis of calciphylaxis was confirmed by a muscle biopsy. Treatment with low calcium peritoneal dialysate and substitution of calcium-based phosphorus binders with sevelamer (Renagel) was unsuccessful. The patient's clinical condition progressed to extensive soft tissue calcification and ulcerating skin lesions. Nine months after the onset of symptoms, the patient died of cardiopulmonary arrest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133040     DOI: 10.1007/s00467-005-2026-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  40 in total

Review 1.  Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis.

Authors:  Sharon M Moe; Neal X Chen
Journal:  Pediatr Nephrol       Date:  2003-10       Impact factor: 3.714

2.  Systemic calciphylaxis revisited.

Authors:  H J Adrogué; M R Frazier; B Zeluff; W N Suki
Journal:  Am J Nephrol       Date:  1981       Impact factor: 3.754

3.  Heparin-induced skin necrosis in a patient with end-stage renal failure and functional protein S deficiency.

Authors:  M D Denton; S Mauiyyedi; H Bazari
Journal:  Am J Nephrol       Date:  2001 Jul-Aug       Impact factor: 3.754

4.  Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.

Authors:  Adrian Fine; James Zacharias
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

Review 5.  Calciphylaxis presenting with calf pain and plaques in four continuous ambulatory peritoneal dialysis patients and in one predialysis patient.

Authors:  A Fine; S Fleming; W Leslie
Journal:  Am J Kidney Dis       Date:  1995-03       Impact factor: 8.860

6.  Therapy for calciphylaxis: an outcome analysis.

Authors:  Jorge E Arch-Ferrer; Samuel W Beenken; Loring W Rue; Kirby I Bland; Arnold G Diethelm
Journal:  Surgery       Date:  2003-12       Impact factor: 3.982

Review 7.  Osteogenic regulation of vascular calcification: an early perspective.

Authors:  Radhika Vattikuti; Dwight A Towler
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05       Impact factor: 4.310

8.  A dialysis patient with systemic calciphylaxis exhibiting rapidly progressive visceral ischemia and acral gangrene.

Authors:  M Tamura; K Hiroshige; A Osajima; M Soejima; M Takasugi; A Kuroiwa
Journal:  Intern Med       Date:  1995-09       Impact factor: 1.271

9.  Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload.

Authors:  D Rubinger; M M Friedlaender; J Silver; Y Kopolovic; W J Czaczkes; M M Popovtzer
Journal:  Am J Kidney Dis       Date:  1986-02       Impact factor: 8.860

10.  Calciphylaxis in a chronic hemodialysis patient with protein S deficiency.

Authors:  L Rostaing; S el Feki; M B Delisle; C Durand-Malgouyres; H Ton-That; J L Bonafe; P Bories; D Durand; J M Suc
Journal:  Am J Nephrol       Date:  1995       Impact factor: 3.754

View more
  7 in total

1.  Rare etiology of severe calf pain and induration in a child with end-stage renal disease: Answers.

Authors:  Gurinder Kumar; Mohammed Khair AlGhabra; Aman Sohal; Baker Ayyash; Nitin Airon; Eihab AlKhasawneh
Journal:  Pediatr Nephrol       Date:  2017-05-04       Impact factor: 3.714

2.  Calciphylaxis in a paediatric patient.

Authors:  Alison Timmis; Henry Morgan
Journal:  BMJ Case Rep       Date:  2010-11-12

Review 3.  Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Authors:  Kurt M Sowers; Melvin R Hayden
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

Review 4.  Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Authors:  Vincent M Brandenburg; Smeeta Sinha; Paula Specht; Markus Ketteler
Journal:  Pediatr Nephrol       Date:  2014-01-29       Impact factor: 3.714

Review 5.  Chronic Kidney Disease and Calciphylaxis: A Literature Review.

Authors:  Munis M Ahmed; Asma Zakir; Muhammad Farhan Ahsraf; Amna Ejaz; Aqsa Ashraf; Lalith Namburu; Muhammad S Farooqi; Moeed Ahmed; Ibrahim Raza
Journal:  Cureus       Date:  2018-09-19

6.  A case report of pediatric calciphylaxis-a rare and potentially fatal under diagnosed condition.

Authors:  Magdalena Stârcea; Cristina Gavrilovici; Andra Elsayed; Mihaela Munteanu; Vasile Valeriu Lupu; Elena Cojocaru; Ingrith Miron; Lucian Miron
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 7.  Calciphylaxis and its diagnosis: A review.

Authors:  Deepak Baby; Meenakshi Upadhyay; M Derick Joseph; Swati Joshi Asopa; Basanta Kumar Choudhury; Jagadish Prasad Rajguru; Shivangi Gupta
Journal:  J Family Med Prim Care       Date:  2019-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.